Adverse event profile of five anti head and neck squamous cell carcinoma drugs: a descriptive analysis from WHO-VigiAccess

BackgroundHead and neck squamous cell carcinoma (HNSCC) remains a significant global health concern, with treatment outcomes for advanced or metastatic stages being suboptimal despite the availability of various targeted therapies and immunotherapies. This study evaluates five FDA-approved anti-HNSC...

Full description

Saved in:

Bibliographic Details
Main Authors:	Weimin Gao, Zhigang Xia, Tingfeng Zhou, Youlin Dong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Pharmacology
Subjects:	HNSCC WHO-vigiaccess anti-HNSCC drugs adverse drug reactions disproportionality analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1602276/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adverse event profile of lomustine and temozolomide: a descriptive analysis from WHO-VigiAccess
by: Hua Luo, et al.
Published: (2025-03-01)

Adverse reactions of four multi-targeted tyrosine kinase inhibitors: a descriptive analysis of the WHO-VigiAccess database
by: Lijun Li, et al.
Published: (2025-04-01)

The real-world analysis of adverse events with azacitidine: a pharmacovigilance study based on the FAERS and WHO-VigiAccess databases
by: Zhaorui Wang, et al.
Published: (2025-03-01)

Characteristic analysis of adverse reactions of histone deacetylase inhibitors based on WHO-VigiAccess
by: Tongnan Yin, et al.
Published: (2025-03-01)

A real-world study of adverse drug reactions of two isocitrate dehydrogenase inhibitor based on the US FDA adverse event reporting system and VigiAccess databases
by: Mengmeng Peng, et al.
Published: (2024-11-01)

Characteristic analysis of adverse reactions of finerenone: an in-depth analysis from WHO-VigiAccess
by: Hongxuan Fan, et al.
Published: (2025-08-01)

Characterization of adverse reactions to four common targeted drugs for hepatocellular carcinoma in WHO-VigiAccess
by: Zeyu Wang, et al.
Published: (2025-05-01)

The characteristics of adverse reactions of three anti-prostate cancer drugs based on Vigiaccess database and bibliometric analysis
by: Jianqing Wang, et al.
Published: (2025-03-01)

Role of Human Papilloma Virus in Carcinogenesis of Head and Neck Squamous Cell
by: Sukri Rahman, et al.
Published: (2024-01-01)

Assessing individual head and neck squamous cell carcinoma patient response to therapy through integration of functional and genomic data
by: Daniel Bottomly, et al.
Published: (2025-06-01)

Prognostic value of lipid metabolism‐related genes in head and neck squamous cell carcinoma
by: Ying Xiong, et al.
Published: (2021-03-01)

Nivolumab resistance in head and neck squamous cell carcinoma patients and future perspectives
by: Karolina Buchajska, et al.
Published: (2025-04-01)

A real-world pharmacovigilance study of adverse drug reactions associated with lecanemab and aducanumab based on WHO-VigiAccess and FAERS databases
by: Haoxiang Hu, et al.
Published: (2025-04-01)

Epithelial-Mesenchymal Transition and Inflammation in Head and Neck Squamous Cell Carcinoma
by: Habib Sadeghi Rad, et al.
Published: (2020-04-01)

Optimizing Prognostic Assessment in High‐Risk Head and Neck Squamous Cell Carcinomas: The Impact of Tumor Budding and a Novel Histomorphological Scoring System
by: Moritz Knebel, et al.
Published: (2025-02-01)

Structured Early Follow-Up in Head and Neck Squamous Cell Carcinomas: A Retrospective Cohort Study
by: Philipp Dittmann, et al.
Published: (2025-05-01)

Oral health and the risk of head and neck squamous cell carcinoma: a multicenter case-control study in Iran
by: Hamideh Rashidian, et al.
Published: (2025-08-01)

Inhibition of head and neck squamous cell carcinoma by Bruton’s tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells
by: Anna R. Bopp, et al.
Published: (2025-05-01)

The characteristics and functional significance of disulfidptosis-related genes in head and neck squamous cell carcinoma
by: Haiqian Zhu, et al.
Published: (2024-12-01)

A hypoxia‐related lncRNA model for prediction of head and neck squamous cell carcinoma prognosis
by: Junwei Xiang, et al.
Published: (2023-02-01)

VPS25 Promotes an Immunosuppressive Microenvironment in Head and Neck Squamous Cell Carcinoma
by: Li-Guo Chen, et al.
Published: (2025-02-01)

Strategies for Anticancer Treatment in p53-Mutated Head and Neck Squamous Cell Carcinoma
by: Bi-He Cai, et al.
Published: (2025-05-01)

Neutrophil/lymphocyte ratio: a potential biomarker in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
by: Marianna Caterino, et al.
Published: (2025-05-01)

TMCO1, as a potential biomarker of prognosis and immunotherapy response, regulates head and neck squamous cell carcinoma proliferation and migration
by: Ting Li, et al.
Published: (2025-05-01)

Upregulated interleukin‐6 expression contributes to erlotinib resistance in head and neck squamous cell carcinoma
by: Aditya Stanam, et al.
Published: (2015-08-01)

Stereotactic body radiation therapy as initial treatment for head and neck cancer
by: Sivakamavalli Jeyachandran
Published: (2024-06-01)

Positron emission tomography directed re-irradiation using volumetric modulated arc technique in recurrent head and neck squamous cell carcinoma
by: Sambit S. Nanda, et al.
Published: (2025-05-01)

Duchenne muscular dystrophy gene product expression is associated with survival in head and neck squamous cell carcinoma
by: Leanne Jones, et al.
Published: (2025-03-01)

Calcium channels as therapeutic targets in head and neck squamous cell carcinoma: current evidence and clinical trials
by: Jinye Lin, et al.
Published: (2024-12-01)

Postoperative complications following salvage neck dissection after (chemo)radiotherapy for head and neck squamous cell carcinoma: which patients are at high risk?
by: Arash Navran, et al.
Published: (2025-05-01)

Comprehensive analysis illustrating the role of HOXB8 in head and neck squamous cell carcinoma: evidence from multi-omics analysis and experiments validation
by: Jun-wei Zhang, et al.
Published: (2025-04-01)

Machine-learning derived identification of prognostic signature to forecast head and neck squamous cell carcinoma prognosis and drug response
by: Sha-Zhou Li, et al.
Published: (2024-12-01)

Radiotherapy outcomes and risk factors for young patients with head-and-neck squamous cell carcinomas: a matched-pair analysis
by: Jiadai Zou, et al.
Published: (2025-04-01)

Efficacy of anti-LAG3 and anti-PD-1 combination checkpoint inhibitor therapy against head and neck squamous cell carcinoma in a genetically engineered mouse model
by: Felipe F. Lamenza, et al.
Published: (2025-12-01)

PINCH-1 promotes tumor growth and metastasis by enhancing DRP1-mediated mitochondrial fission in head and neck squamous cell carcinoma
by: Ruxian Tian, et al.
Published: (2025-12-01)

A prognostic model for head and neck squamous cell carcinoma based on radiotherapy sensitivity insights from nasopharyngeal carcinoma
by: Yinjiao Fei, et al.
Published: (2025-05-01)

Emergence of advanced immunotherapy: New horizons for HPV-negative head and neck squamous cell carcinoma
by: Madhan Krishnan, et al.
Published: (2024-12-01)

Gene expression profiling and pathway analysis in head and neck squamous cell carcinoma: focus on disulfidptosis
by: Yajun Tong, et al.
Published: (2025-04-01)

A computational study of gene expression patterns in head and neck squamous cell carcinoma using TCGA data
by: Saqib Rauf, et al.
Published: (2024-12-01)

USP5 Promotes Head and Neck Squamous Cell Carcinoma Progression via mTOR Signaling Pathway
by: Ni Xiong, et al.
Published: (2025-03-01)